ORLANDO, Fla., May 12, 2011 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international, small-cap research and financial public relations firm, today announced that it has terminated its investor relations agreement with Weikang Bio-Technology Group Co., Inc. ("Weikang").
On May 12, 2011, RedChip provided notice of termination to Weikang, effective immediately. The termination was based primarily on the fact that officers of Weikang did not make themselves available to RedChip analysts.
About RedChip Companies, Inc.
RedChip Companies is an international, small-cap research and financial public relations firm headquartered in Orlando, Florida; with affiliate offices in Beijing, China and Seoul, Korea. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research™, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Small-Cap TV™, Shareholder Intelligence, Social Media and Blogging Services, Webcasts, and RedChip Radio™. To learn more about RedChip's products and services, please visit: http://www.redchip.com/visibility/productsandservices.asp.
The RedChip Companies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2761
"Discovering Tomorrow's Blue Chips Today"™